BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bashir AO, El-mesery ME, Anwer R, Eissa LA. Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma. Life Sciences 2020;254:117794. [DOI: 10.1016/j.lfs.2020.117794] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Z, Liu L, Li S, Hou X, Yang J. Advances in research on the relationship between thymoquinone and pancreatic cancer. Front Oncol 2022;12:1092020. [PMID: 36686732 DOI: 10.3389/fonc.2022.1092020] [Reference Citation Analysis]
2 Tadros SA, Attia YM, Maurice NW, Fahim SA, Abdelwahed FM, Ibrahim S, Badary OA. Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p. Int J Mol Sci 2022;23. [PMID: 36555545 DOI: 10.3390/ijms232415904] [Reference Citation Analysis]
3 Ashour H, Farghaly ME, Khowailed AA, Aboulhoda BE, Rashed LA, Elsebaie MM, Gaber SS. Modulation of miR-192/NF-κB/ TGF-β/ E-cadherin by thymoquinone protects against diethylnitrosamine /carbon tetrachloride hepatotoxicity. PhysInt 2022. [DOI: 10.1556/2060.2022.00163] [Reference Citation Analysis]
4 Saddiq AA, El-far AH, Mohamed Abdullah SA, Godugu K, Almaghrabi OA, Mousa SA. Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression. Front Pharmacol 2022;13:936996. [DOI: 10.3389/fphar.2022.936996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fang Y, Yan D, Wang L, Zhang J, He Q. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma. J Clin Lab Anal 2022;:e24541. [PMID: 35666610 DOI: 10.1002/jcla.24541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Farooqi AA, Attar R, Xu B. Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone. IJMS 2022;23:6311. [DOI: 10.3390/ijms23116311] [Reference Citation Analysis]
7 Alam M, Hasan GM, Ansari MM, Sharma R, Yadav DK, Hassan MI. Therapeutic implications and clinical manifestations of thymoquinone. Phytochemistry 2022. [DOI: 10.1016/j.phytochem.2022.113213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Homayoonfal M, Asemi Z, Yousefi B. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis. Cell Mol Biol Lett 2022;27:21. [PMID: 35236304 DOI: 10.1186/s11658-022-00320-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Yang C, Shangguan C, Cai C, Xu J, Qian X. LncRNA HCP5 Participates in the Tregs Functions in Allergic Rhinitis and Drives Airway Mucosal Inflammatory Response in the Nasal Epithelial Cells. Inflammation 2022. [PMID: 35122570 DOI: 10.1007/s10753-022-01620-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Farooq J, Sultana R, Taj T, Asdaq SMB, Alsalman AJ, Mohaini MA, Al Hawaj MA, Kamal M, Alghamdi S, Imran M, Shahin H, Tabassum R. Insights into the Protective Effects of Thymoquinone against Toxicities Induced by Chemotherapeutic Agents. Molecules 2021;27:226. [PMID: 35011457 DOI: 10.3390/molecules27010226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G. Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways. J Hepatocell Carcinoma 2021;8:1415-44. [PMID: 34858888 DOI: 10.2147/JHC.S336858] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
12 Tabassum S, Rosli N, Ichwan SJA, Mishra P. Thymoquinone and its pharmacological perspective: A review. Pharmacological Research - Modern Chinese Medicine 2021;1:100020. [DOI: 10.1016/j.prmcm.2021.100020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Abd-rabou AA, Edris AE. Cytotoxic, apoptotic, and genetic evaluations of Nigella sativa essential oil nanoemulsion against human hepatocellular carcinoma cell lines. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00101-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Homayoonfal M, Asemi Z, Yousefi B. Targeting microRNAs with thymoquinone: a new approach for cancer therapy. Cell Mol Biol Lett 2021;26:43. [PMID: 34627167 DOI: 10.1186/s11658-021-00286-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Atteia HH, Arafa MH, Mohammad NS, Amin DM, Sakr AT. Thymoquinone upregulates miR-125a-5p, attenuates STAT3 activation, and potentiates doxorubicin antitumor activity in murine solid Ehrlich carcinoma. J Biochem Mol Toxicol 2021;:e22924. [PMID: 34605108 DOI: 10.1002/jbt.22924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Wei J, Lu Y, Wang R, Xu X, Liu Q, He S, Pan H, Liu X, Yuan B, Ding Y, Zhang J. MicroRNA-375: potential cancer suppressor and therapeutic drug. Biosci Rep 2021;41:BSR20211494. [PMID: 34494089 DOI: 10.1042/BSR20211494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhou X, Wang F, Wu H, Chen X, Zhang Y, Lin J, Cai Y, Xiang J, He N, Hu Z, Jin X. Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells. Int J Biol Sci 2021;17:3456-75. [PMID: 34512159 DOI: 10.7150/ijbs.60401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Pal RR, Rajpal V, Singh P, Saraf SA. Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis. Pharmaceutics 2021;13:775. [PMID: 34067322 DOI: 10.3390/pharmaceutics13060775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
19 Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN. Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals (Basel) 2021;14:369. [PMID: 33923474 DOI: 10.3390/ph14040369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
20 Abo El-Magd NF, El-Mesery M, El-Karef A, El-Shishtawy MM. Amelioration effect of black seed oil against high-fat diet-induced obesity in rats through Nrf2/HO-1 pathway. J Food Biochem 2021;45:e13693. [PMID: 33719073 DOI: 10.1111/jfbc.13693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, Taheri M. MicroRNA signature in liver cancer. Pathol Res Pract 2021;219:153369. [PMID: 33626406 DOI: 10.1016/j.prp.2021.153369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
22 Elgohary S, Elkhodiry AA, Amin NS, Stein U, El Tayebi HM. Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? Cells 2021;10:302. [PMID: 33540625 DOI: 10.3390/cells10020302] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]